Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

‘Stealthy’ new Covid variant can reinfect you every month

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

The Independent UK

How Rwanda could become one of the first countries to wipe out cervical cancer

With a strong HPV vaccination programme for girls and a concerted screening and treatment drive for women, the country could be the first in Africa to eliminate the disease

The Guardian - UK

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Health Department knew of vaccine rollout risks but did nothing to address them

The auditor-general has examined last year’s vaccine rollout and looked at why it was so slow in aged care and disability care.

Crikey

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Benzinga

Study suggests having a Covid-19 jab while pregnant ‘not linked to stillbirth’

Academics in Canada looked at data on 85,162 births where half of the mothers had received a coronavirus vaccine during pregnancy.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

JCVI issues autumn Covid booster update as new vaccine approved

The Joint Committee on Vaccination and Immunisation has confirmed which vaccines are appropriate for the autumn booster following the new dual variant vaccine that targets Omicron and original variant.

Edinburgh Live

Monkeypox vaccine could run out in parts of UK due to 'short supply'

Some areas could be without jabs for three to four weeks

Daily Record

India supplies nearly 60% of vaccines used worldwide: Nirmala Sitharaman

India today is double dosing every citizen and produced COVID-19 vaccines even during the lockdown period, said Union Finance Minister Nirmala Sitharaman

The Hindu

Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation Highest In 40 Years, Sole Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand And Other Top Financial Stories Wednesday, August 17

CNBC BlackRock To Pledge A$1B In Australian Battery Storage Assets – Report

Benzinga

Planning for COVID-19 vaccine rollout left too late, Commonwealth failed to adequately engage states, damning review finds

The former Morrison government's planning for Australia's COVID-19 vaccine rollout was not "timely", it underestimated how difficult it would be to protect aged care and disability residents and failed to adequately engage with the states and territories before the rollout began, a damning review has found.

ABC News

‘Stealthy’ new Covid variant can reinfect you every month

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

The Independent UK

Monkeypox outbreak has plateaued but vaccine shortages possible – health chief

Dame Jenny Harries said there are now around 20 cases a day, compared to 35 two weeks ago.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Dublin Live

Over 100,000 people in Dublin could have Long Covid with stark warning for health system

The country is facing "a very significant and growing problem" with Long Covid, according to TD

Wales Online

Monkeypox vaccine may run out, confirms UKHSA

Some areas could be left with no vaccine for three or four weeks

The Independent UK

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Guardian - AU

Morrison government failed to provide priority for at-risk groups in vaccine rollout, report says

National audit report on vaccine rollout found planning ‘was not timely’ and distribution to priority populations had not ‘met targets’

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

A researcher asked COVID anti-vaxxers how they avoid Facebook moderation. Here's what they found

How are social media platforms managing vaccine misinformation at this stage in the pandemic?

Tribune News Service

Does decades-old smallpox vaccination protect against monkeypox?

Health officials are scrambling to stretch scarce doses of vaccine to slow the mounting monkeypox outbreak, but do older people already vaccinated as kids for the related but deadlier smallpox virus already have protection?

The Independent UK

BCG vaccine can protect against Covid, new report finds

The report suggests that the BCG tuberculosis vaccine can significantly strengthen the immune system

Daily Mirror

All over-50s to get a new Covid jab targeted to protect against Omicron variant

Britain became the first country to approve a “bivalent” jab on Monday that directly targets Omicron and the original Covid-19 strain - as 29 million people will initially be invited for the vaccine

The Guardian - UK

The Guardian view on polio: we have the tools to tackle this old enemy

Editorial: The emergence of cases in the UK, US and elsewhere is a warning that the progress made in curbing the disease must be protected

The Independent UK

‘No second-rate vaccines’ health chief insists as half will miss out on dual-strain booster

Roughly 29 million people are eligible for an autumn booster but there are just 13 million doses of the new bivalent Moderna jab available

The Guardian - UK

No plans for UK to order more supplies of AstraZeneca Covid vaccine

JCVI says mRNA vaccines such as the Pfizer and Moderna jabs are the most effective for UK booster programme

1 … 133 134 135 136

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.